Follow Slashdot blog updates by subscribing to our blog RSS feed

 



Forgot your password?
typodupeerror

Slashdot videos: Now with more Slashdot!

  • View

  • Discuss

  • Share

We've improved Slashdot's video section; now you can view our video interviews, product close-ups and site visits with all the usual Slashdot options to comment, share, etc. No more walled garden! It's a work in progress -- we hope you'll check it out (Learn more about the recent updates).

×
Advertising Communications Government Media Medicine Social Networks United States Your Rights Online News

Pharma Marketing Faces a Character-Count Conundrum 176

Posted by timothy
from the another-dose-of-nanny-state-should-do-it dept.
this_boat_is_real writes "There's growing concern over how pharmaceutical companies use social media and the Internet to market their products. Last November, the US Food and Drug Administration held a hearing on the topic, and many were worried over how marketing mediums such as Twitter — which has a 140-character limit on text — can sufficiently disclose drug risks." Here's the FDA's announcement about last year's hearings, which includes links to an archive of presentations as well as a video record of the meeting.
This discussion has been archived. No new comments can be posted.

Pharma Marketing Faces a Character-Count Conundrum

Comments Filter:

Nothing is more admirable than the fortitude with which millionaires tolerate the disadvantages of their wealth. -- Nero Wolfe

Working...